Biopharmaceutical company
Ongoing discussions surrounding next steps for protecting and promoting incentives for the development of resistant pathogens including breakpoints; 
antibiotic resistance among elderly population;
issues related to 340B Drug Pricing Program;reimbursement issues for antibiotics;

H.R. 4187, DISARM - Developing An Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2014
HCR - Health Issues
1 - SENATE
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
TRACY SPICER AMY TEJRAL ELIZABETH MACDONALD BARNETT